Paracetamol/acetaminophen usage in haemophilia: More caution needed?

Haemophilia

Volumn 14, Issue 3, 2008, Pages 434-435

  Van Veen, J J ^a   Gleeson, D C ^b   Makris, M ^b  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b Sheffield Dental Hospital   (United Kingdom)

Author keywords

Acetaminophen; Haemophilia; Hepatotoxicity; Liver disease; Paracetamol

Indexed keywords

ACETONE; ALCOHOL; ANTICONVULSIVE AGENT; CYCLOOXYGENASE 2 INHIBITOR; CYTOCHROME P450 1A2; CYTOCHROME P450 2E1; GLUTATHIONE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; TUBERCULOSTATIC AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING DISORDER; CARDIOVASCULAR RISK; DRUG ALCOHOL INTERACTION; DRUG METABOLISM; DRUG OXIDATION; DRUG SAFETY; DRUG SULFATION; DRUG USE; ETHNIC DIFFERENCE; GASTROINTESTINAL HEMORRHAGE; HEMOPHILIA; HUMAN; LIVER DISEASE; LIVER FAILURE; LIVER TOXICITY; OSTEOARTHRITIS; PAIN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE FUNCTION;

ACETAMINOPHEN; ALANINE TRANSAMINASE; ANALGESICS, NON-NARCOTIC; ARTHRITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMARTHROSIS; HEMOPHILIA A; HUMANS; LIVER; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 43149101506     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01653.x     Document Type: Review

References (19)

1. Raffini L, Manno C. Modern management of haemophilic arthropathy. [Review] [105 refs]. Br J Haematol 2007; 136: 777-7.
2. Bombardier C, Laine L, Reicin A et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000; 343: 1520-8.
3. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006; 332: 1302-8.
4. O'Grady JG, Schalm SW, Williams R. Acute liver failure: Redefining the syndromes. Lancet 1993; 342: 273-5.
5. Rumack BH. Acetaminophen hepatotoxicity: The first 35years. J Toxicol Clin Toxicol 2002; 40: 3-20.
6. Watkins PB, Kaplowitz N, Slattery JT et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: A randomized controlled trial. JAMA 2006; 296: 87-93.
7. Gonzalez FJ. CYP2E1. Drug Metab Dispos 2007; 35: 1-8.
8. O'Grady JG. Broadening the view of acetaminophen hepatotoxicity. Hepatology 2005; 42: 1252-4.
9. Prescott LF. Paracetamol, alcohol and the liver. Br J Clin Pharmacol 2000; 49: 291-301.
10. Garfein RS, Bower WA, Loney CM et al. Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B. Hepatology 2004; 40: 865-73.
11. Yaghi C, Honein K, Boujaoude J, Slim R, Moucari R, Sayegh R. Influence of acetaminophen at therapeutic doses on surrogate markers of severity of acute viral hepatitis. Gastroenterol Clin Biol 2006; 30: 763-8.
12. Barbaro G, Di Lorenzo G, Soldini M et al. Hepatic glutathione deficiency in chronic hepatitis C: Quantitative evaluation in patients who are HIV positive and HIV negative and correlations with plasmatic and lymphocytic concentrations and with the activity of the liver disease. Am J Gastroenterol 1996; 91: 2569-73.
13. Critchley JA, Nimmo GR, Gregson CA, Woolhouse NM, Prescott LF. Inter-subject and ethnic differences in paracetamol metabolism. Br J Clin Pharmacol 1986; 22: 649-57.
14. Yin OQ, Tomlinson B, Chow AH, Chow MS. Pharmacokinetics of acetaminophen in Hong Kong Chinese subjects. Int J Pharm 2001; 222: 305-8.
15. American college of rheumatology subcommittee on osteoarthritis. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000; 43: 1905-15.
16. Benson GD, Koff RS, Tolman KG. The therapeutic use of acetaminophen in patients with liver disease. Am J Ther 2005; 12: 133-41.
17. Dart RC, Kuffner EK. Use of acetaminophen in alcoholic patients: Comment on the 2000 update of the American College of Rheumatology recommendations for management of hip and knee osteoarthritis. Arthritis Rheum 2001; 44: 2449-6.
18. Kuffner EK, Dart RC, Bogdan GM, Hill RE, Casper E, Darton L. Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 2001; 161: 2247-52.
19. Kuffner EK, Temple AR, Cooper KM, Baggish JS, Parenti DL. Retrospective analysis of transient elevations in alanine aminotransferase during long-term treatment with acetaminophen in osteoarthritis clinical trials. Curr Med Res Opin 2006; 22: 2137-48.